SMAIO SA (ALSMA.PA) Stock Price & Overview
EPA:ALSMA • FR0014005I80
Current stock price
The current stock price of ALSMA.PA is 7.7 EUR. Today ALSMA.PA is down by -0.26%. In the past month the price increased by 8.45%. In the past year, price increased by 95.43%.
ALSMA.PA Key Statistics
- Market Cap
- 47.432M
- P/E
- N/A
- Fwd P/E
- 149.51
- EPS (TTM)
- -0.35
- Dividend Yield
- N/A
ALSMA.PA Stock Performance
ALSMA.PA Stock Chart
ALSMA.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ALSMA.PA. When comparing the yearly performance of all stocks, ALSMA.PA is one of the better performing stocks in the market, outperforming 95.01% of all stocks.
ALSMA.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ALSMA.PA. The financial health of ALSMA.PA is average, but there are quite some concerns on its profitability.
ALSMA.PA Earnings
ALSMA.PA Forecast & Estimates
10 analysts have analysed ALSMA.PA and the average price target is 8.52 EUR. This implies a price increase of 10.61% is expected in the next year compared to the current price of 7.7.
For the next year, analysts expect an EPS growth of 35% and a revenue growth 67.27% for ALSMA.PA
ALSMA.PA Groups
Sector & Classification
ALSMA.PA Financial Highlights
Over the last trailing twelve months ALSMA.PA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 36.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.39% | ||
| ROE | -25% | ||
| Debt/Equity | 0.33 |
ALSMA.PA Ownership
ALSMA.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.18 | 94.93B | ||
| 2M6 | MEDTRONIC PLC | 13.7 | 94.468B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.37 | 43.191B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.12 | 24.333B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.1 | 23.9B | ||
| BIM | BIOMERIEUX | 18.8 | 10.67B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.83 | 3.811B | ||
| DIA | DIASORIN SPA | 15.66 | 3.528B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.9 | 2.51B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.86 | 1.829B | ||
| DRW8 | DRAEGERWERK AG | 9.2 | 1.426B | ||
| ELN | EL.EN. SPA | 17.72 | 1.075B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.83 | 976.938M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find more growth stocks the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALSMA.PA
Company Profile
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
Company Info
IPO: 2022-04-06
SMAIO SA
2 Place Berthe Morisot, Parc Technologique
Saint-Priest AUVERGNE-RHONE-ALPES FR
Employees: 41
Phone: 33469842302
SMAIO SA / ALSMA.PA FAQ
What does ALSMA do?
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
Can you provide the latest stock price for SMAIO SA?
The current stock price of ALSMA.PA is 7.7 EUR. The price decreased by -0.26% in the last trading session.
Does SMAIO SA pay dividends?
ALSMA.PA does not pay a dividend.
What is the ChartMill rating of SMAIO SA stock?
ALSMA.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is ALSMA.PA stock listed?
ALSMA.PA stock is listed on the Euronext Paris exchange.
Can you provide the growth outlook for SMAIO SA?
The Revenue of SMAIO SA (ALSMA.PA) is expected to grow by 67.27% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.